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This research purposed to optimize, investigate and 
evaluate the influence of xanthan gum, sodium bicarbonate-citric 
acid as effervescent components and hardness on floatation 
behavior and drug release of gastro-floating captopril tablet with 
floating system. A 23 full factorial design (8 runs) was applied to 
optimize the floating captopril tablet using xanthan gum (X1), 
ratio of effervescent components (X2) and hardness (X3) as 
independent variables. Optimum area was determined by 
superimposed contour plot of floating lag time (Y1), cumulative 
drug release at 60min (Q60) (Y2) and drug release constant rate 
(Y3) using Design Expert
® software. Xanthan gum, effervescent 
components and hardness were affected the floatation behavior 
and drug release. Hardness was the most dominant factor 
affected the floatation behavior and drug release. Based on 
superimposed contour plot, the optimum area was in range of 
xanthan gum 58–100mg, sodium bicarbonate 45–63mg, citric 
acid 7–25mg and hardness at 70–98N. 
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INTRODUCTION 
Captopril (CAP) is an angiotensin 
converting enzyme inhibitor as hypertension 
treatment with half-life about 2h. CAP as  
highly water soluble drug is most stable at 
acidic condition and unstable in intestine or  
pH increases with degradation reaction.           
These indicate a promising potential as 
gastroretentive drug delivery system to improve 
the bioavailability and prolong the drug release 
(Nur and Zhang, 2000). 
Floating drug delivery system with 
effervescent system is using effervescent 
components to accelerate floatation and matrix 
to control the drug release. Sodium bicarbonate 
and acid system act as effervescent components, 
increasing of bicarbonate proportion reduced 
floating lag time and floating time. Excess the 
effervescent components causing the drug 
release uncontrolled and tablet cannot maintain 
their integrity (Jaimini et al., 2007). Baumgartner 
et al. (2001) showed that hardness affected on 
floatation behavior. Low compression force 
causing tablet float in medium and tablet sink 
when high compression force was applied 
(Chen et al., 2013). 
Initial burst release indicates the drug 
release at initial time before reach the constant 
release. Burst release promotes high doses 
release uncontrolled (dose dumping) and 
reduce life time of controlled release 
formulation (Huang and Brazel, 2001). Xanthan 
gum (XG) provide several advantages than  
hydroxyl propyl methyl cellulose (HPMC) with 
no initial burst release effect in water soluble 
drug with rapidly hydration, more reproducible 
and release the drug followed by zero-order 
release (Bhardwaj et al., 2000). HPMC act as 
retarding release agent for sustained release 
formulation, form firm gel resistant of diffusion 
and erosion (Siepmann and Peppas, 2012). 
Combination of both polymers eliminate the 
limitations on single polymer system and may 
be suitable for formulation of sustained release 
matrix of highly water soluble drug to reduce 
the initial burst release  effect (Tiwari et al., 
2011). 
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This study aimed to optimize, investigate 
and evaluate the influence of XG, sodium 
bicarbonate-citric acid as effervescent 
components and hardness on floatation behavior 
and drug release of gastro-floating CAP tablet 
with floating system using 23 full factorial 
design. 
 
MATERIAL AND METHOD 
CAP was purchased form Afine 
Chemicals Limited (Hangzou, China), Methocel® 
K15M (HPMC K15 M) as gift from Colorcon 
(USA), Avicel® PH101 (MMC) (Shin-Etsu, 
Japan), Plasdone® K29/32 (PVP K30) (Ashland, 
USA), XG (Qingdao ICD Biochemistry, China), 
citric acid (Waifang Ensign, China), sodium 
bicarbonate (Honghe Chemicals, China), 
magnesium stearate (Peter Greven, Germany), 
and talk (Bratachem, Indonesia) were purchased 
from Bratachem Chemicals (Surakarta, 
Indonesia) and all the chemicals in pharma-
ceuticals grade. Calsium sulfate (Merck, 
Germany), ethanol (Merck, Germany), methanol 
(Merck, Germany), hydrochloric acid 
(Mallinckrodt, Ireland) all the chemicals in 
analytical grade and demineralized water. 
 
Drug-excipients compatibility study 
Drug-excipients compatibility study           
was conducted using FT-IR Shimadzu 8400S 
(Kyoto, Japan) to determine the interaction 
between   CAP   and    excipients.    The    pure           
drug and mixtures (in equal ratio) with 
excipients were scanned using potassium 




Tablets were formulated using CAP                
as drug model 50mg, Methocel® K15M  
120mg, Plashdone® 15mg, calcium sulfate 
30mg, talk 7.2mg, magnesium stearate 0.8mg, 
effervescent components (using ratio of 
sodium bicarbonate-citric acid with total 
amount 70mg) and XG based on factorial 
design model according in tablet I. Wet 
granulation method was employed for 
formulation. All of the components in formula 
except magnesium stearate and talk were passed 
through sieve no.30 separately and mixed in the 
cube mixer for 15min 30rpm followed by 
addition 10% PVP in ethanol solution to the 
blend until elastic mass of wet granules were 
achieved. Mass of wet granules were passed 
through sieve no.16 and were dried in oven at 
temperature 40oC for 3h. The dried granules 
were passed through sieve no.18 and mixed with 




The tablet compression process using 
single punch machine tablet model TDP-1 
Shanghai   (China),   granules    were   weighted  
Table I. A 23 factorial design models and the results of floating lag time and drug release 
 
Formula 
Coded factor level Results 
X1 X2 X3 Y1 (sec) Y2(%) Y3 (mg/min) 
F1 -1 -1 -1 19.5±1.4 30.86±1.54 0.1041±0.0006 
Fa +1 -1 -1 24.8±3.9 25.69±1.89 0.0866±0.0008 
Fb -1 +1 -1 10.3±1.2 34.43±2.18 0.1100±0.0021 
Fab +1 +1 -1 28.2±3.4 26.02±0.72 0.0975±0.0050 
Fc -1 -1 +1 4881.0±118.4 31.22±3.27 0.0885±0.0036 
Fac +1 -1 +1 3620.8±92.8 25.45±2.74 0.0760±0.0028 
Fbc -1 +1 +1 1913.8±64.9 25.52±0.60 0.0803±0.0017 
Fabc +1 +1 +1 1102.2±84.1 17.35±2.29 0.0731±0.0008 
       
Coded level -1 +1 
X1 : XG (mg) 20 100 
X2 ; Sodium bicarbonate-citric acid ratio 6:4 9:1 
X3 ; hardness (N) 60 120 
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manually 400mg and compressed using flat-face 
punch (diameter 10mm). The hardness was 
maintained at 60N for low level and 120N for 
high level of hardness factor. 
 
Physical properties of CAP floating tablet 
Physical properties of tablets were 
conducted by thickness of tablet using calipers 
(accuracy 0.02mm), friability using Erweka 
GMB-H friability tester, hardness using Stokes 
Mosanto hardness tester and drug content. 
 
Floatation behavior characterization 
Floating lag time (FLT) and floating time 
(FT) of tablets were determined using 200mL 
of HCl 0.1mol/L in a beaker glass. The time 
required tablet to rise to the surface and float 
constantly as FLT and the total duration of 
floating in medium as FT were determined. 
 
In-Vitro drug release 
The drug release was determined using 
dissolution tester (Electrolab TDT 08L) type 
apparatus II (paddle method) standard USP 
XXXII using sinker to avoid the tablet float, 
where 900mL of HCl 0.1mol/L were used as 
dissolution medium was maintained at 
37±0.5oC at 50 rpm of speed rotation for             
6h. Aliquots of 5mL were withdrawn at 15, 30, 
45, 60, 90, 120, 180, 240, 300 and 360min               
with replacement of 5mL of the fresh media. 
All the samples were diluted with dissolution 
medium (when necessary) and were analyzed at 
202.9nm using an UV-Vis Hitachi U-2900 
spectrophotometer. 
 
Drug release kinetics 
Several mathematic models were applied 
to analyze the drug release data to find the   
best fitting equation models i.e. zero-order 
release, first-order release, Hixson-Crowell, 
Weibull, Higuchi release, non linier regression 
using     quadratic     model  and Korsmeyer-Peppas 
equation. The release mechanism based on the 
exponential diffusion value (n) of Korsmeyer 
Peppas equation. The best fitting equation 
based on goodness of fit using coefficient of 
determination (R2) and least square fit i.e. AIC 
(Akaike’s Information Criterion) and RMSE 
(root mean square error). Drug release kinetics 
and mechanism were computed using open 
source software KinetDS® version 3.0 (Mendyk 
et al., 2012) and DDSolver® version 1.0 (Zhang 
et al., 2010). 
 
Statistical analysis and optimization 
Data obtained (FLT, Q60 and drug 
release constant rate) were analyzed using 
Design Expert® software version 7.1.5 (Stat-
Ease Inc., Minneapolis, MN, USA). Factorial 
models, including the intercept, main effect and 
interactions were generated for all the response 
variables using multiple linear regression 
analysis (MLRA) approach. The models were 
evaluated based on several statistical parameters, 
including the determination coefficient (R2), 
adjusted determination coefficient (Adj. R2), 
predicted determination coefficient (Pred. R2) 
and adequate precision (adeq. precision).  
The significant effect of factor on 
response were determined by F test or p value 
of analysis of variance (ANOVA) with 
confidence interval of 95% (p=0.05) were also 
calculated using Design Expert® software. 
Contour plots were constructed based on 
equation of responses, these plots are useful to 
elucidate interaction effects of factor on 
responses. The optimum formula determined 
using superimposed contour plot was obtained 
from combination of contour plot for each 
parameter (Bolton and Bon, 2004). 
 
RESULT AND DISCUSSION 
Drug-excipients compatibility studies 
FT-IR spectra of CAP with mixtures of 
HPMC and XG (polymers), CAP-effervescent 
components, and CAP-all excipients were 
presented in figure 1. The principal peaks of 
CAP were at wavenumbers 1589.34 and 
1747.51cm-1 were assigned carbonyl stretching 
vibration of amide and carboxylic acid 
respectively. Peaks at 1332.81 was assigned       
O-H binding vibration, 1228.66cm-1 was 
assigned C-O stretching vibration, 1203.58cm-1 
was assigned C-N stretching vibration, 
2565.33cm-1 was assigned a thiol group (SH)  
stretching vibration. Degradation and 
incompatibilities were showed by new strong or 
sharp peak at 650-600cm-1 as disulfide form (S-
S) and disappeared vibration of thiols group, 
those were not found in CAP mixtures with 
effervescent components, polymers and all 
excipients. There was no significant shift of 
principal   peaks of CAP in the mixture of    CAP 
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with polymers, effervescent components and all 
excipients, thus indicating that no chemical 
interaction between drug and excipients. 
 
Physical properties of tablets 
Physical properties of tablet showed that 
at low level and high level of hardness factor 
was successfully controlled respectively at 60N 
(59-63N) and 120N (116-121N), results showed 
not significant different statistically (p>0.01) 
for each level. The hardness of tablets affected 
friability of tablet, at high level (0.00-0.02%) 
provided lower friability than low level (0.06-
0.12%) of hardness factor. Difference of tablet 
thickness was affected of the compression 
force, while adjusted the deepness of upper 
punch to achieve the hardness according to the 
hardness level and difference of compressed 
mass properties. The drug content required the 
standard reference with not less than 90% and 




FLT for all formulation within 10-4481s 
(Table I) and all of the formulas provided 
duration of FT more than 24h. Based on the 
FLT, MLRA approach using factorial design 
method for studied the response of factor in 
FLT was expressed in equation 1. 
 
Ln(Y1) = 5.39 + 0.049X1 – 0.33X2 + 2.43X3 +  
0.064X1X2 – 0.26X1X3 – 0.20X2X3 – 0.13X1X2X3 
…....….. (1) 
 
  Ratio maximum data and minimum 
data in FLT more than 10 (496.2) thus the FLT 
must be transformed in natural log (ln) for 
required plot of the residual distributed 
normally. Eq. 1 showed that hardness was the 
most dominant in increasing FLT. Increasing 
the hardness reduced the porosity and 
increased the density thus causing longer of 
FLT. Previous work showed the hardness and 
compression force affected the buoyancy 
properties (Baumgartner et al., 2000; Chen et al., 
2013). Enhancement of XG level increased the 
bulk and tapped density (data not shown) thus 
affected in increasing FLT and increasing the 
filler (MMC) (when XG level decreased) 
provided shorter FLT.  
Enhancement of the effervescent 
components ratio (increasing sodium 
bicarbonate proportion) reduced the FLT. 
Sodium bicarbonate as gas generating agent 
produce gas after reaction with acidic medium 
and gas entrapped in swollen matrix then tablet 
becomes buoyant. Increasing the proportion of 
sodium bicarbonate provided shorter FLT  
(Rao et al., 2009; Srikant et al., 2011; Hu et al., 
2011). FLT was not only affected by the factors  
 
 
Figure 1. FT-IR spectrum of mixture between CAP and excipients (blue band : CAP, green band : 
CAP-polymers, black band : CAP-effervescent components, red band : CAP-all excipients) 
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optimized, however FLT was affected by 
interaction of each factor. Interaction between 
X1-X2 increased the FLT, interaction between 
X2-X3 and X1-X3 reduced FLT and interaction 
of   all   factors   reduced   FLT.  The   model in  
significant term (p<0.05) and all of the       
factors and their interactions provided 
significant effect in FLT (p<0.05). Interaction 





Figure 2. Contour plot of FLT a) X3 at low level, b) X3 at high level, 





Figure 3. Drug release profiles of CAP gastro-floating tablet. 
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Figure 4. Contour plot of Q60 a) X1 at low level, b) X1 at high level, 




Figure 5. Contour plot of drug release rate a) X1 at low level, b) X2 at 
low level, c) X3 at low level and d) X3 at high level. 
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Drug release 
Drug release of from gastro-floating 
CAP tablet was showed in figure 3. All 
formulas had similarity on drug release pattern. 
Formulas with low level of hardness factor 
showed the higher drug release than formulas 
with high level of hardness. Increasing of 
hardness reduced the porosity and water-uptake 
thus decreased drug release (Ferrero and 
Jimenez-Castellanos, 2014). 
Increasing the sodium bicarbonate 
promoted the drug release, sodium bicarbonate 
produce gas after reaction with acidic medium 
that causing the matrix became porous and the 
drug diffusion pass through the porous/ 
channel, hence increased the drug release. Citric 
acid accelerated the effervescent reaction thus 
increased the drug release at initial time. Drug 
release of all formulas were retarded for 6h. 
Based on the Q60, MLRA approach 
using factorial design method for studied the 
response of factor in Q60 was expressed in 
equation 2. 
 
Y2 = 27.07 – 3.44X1 – 1.24X2 – 2.18X3 – 0.70X1X2 
– 0.045X1X3 – 2.21X2X3 + 0.10X1X2X3 …….(2) 
 
Eq. 2 showed that XG was the most 
dominant factor to reduce the drug release at 
60min. CAP as drug model have highly soluble 
drug in matrix HPMC showed the initial burst 
release effect (Patel et al., 2008). Combination 
of HPMC and XG reduced initial burst release 
rather than single polymer (Mughal et al., 2011; 
Tavakoli et al., 2006). Increasing hardness and 
reducing the citric acid proportion reduced the 
Q60. Q60 was not only affected by the factors 
optimized, however interaction of each factor 
affected Q60. Interaction between X1-X2, X2-X3 
and X1-X3 reduced Q60 and interaction of all 
factors increased Q60. The equation of Q60 had 
significant term (p<0.05). XG, effervescent 
components and interaction between 
effervescent components and hardness 
provided significant effect on drug release at 
initial time (p<0.05). Interaction of factor was 
elucidated using contour plot (Figure 4). 
Drug release rate constant (Y3) based on 
the slope of zero-order release kinetics. MLRA 
approach using factorial design method for 
studied the response of factor in Y3 was 
expressed in equation 3. 
Y3 = 0.089 – 6.213x10-3X1 + 7.125x10-4X2 – 
0.010X3 + 1.296x10-3X1X2 + 1.288x10-3X1X3 – 
3.487x10-3X2X3 + 4.583x10-5X1X2X3 ……....(3) 
 
Eq. 3 showed that hardness was the 
most dominant on reducing the drug release 
rate, increasing of effervescent components 
level increased the drug release rate, with 
increasing the sodium bicarbonate-citric acid 
ratio. XG reduced the drug release rate, 
increasing the polymer concentration reduced 
the drug release and drug release rate 
(Mostavafi et al., 2011). Interaction between X1-
X2 and X1-X3 increased the drug release rate, 
interaction between X2-X3 reduced the drug 
release rate. Main effects (X1, X2 and X3), 
interactions of each factor and all factors 
affected the drug release rate. Eq. 3 had 
significant term (p<0.05) and the XG,  
hardness and interaction of each factor 
provided significant effect on drug release rate 
(p<0.05).   
Based on statistical parameters of 
factorial design method, R2 measure the 
influence of factor to the response in equation, 
thus the higher of R2 more preferable (ln(Y1) = 
0.999, Y2 = 0.890 and Y3 = 0.971). Adj. R2 
(ln(Y1) = 0.999, Y2 = 0.851 and Y3 = 0.959) 
and Pred. R2 (ln(Y1) = 0.998, Y2 = 0.752 and Y3 
= 0.936) should be within 0.200 of each other. 
Adeq. precision showed the signal to noise 
ratio, adeq. precision more than 4 was desirable 
model (ln(Y1) = 140.7, Y2 = 14.1 and Y3 = 
24.4) thus all response had adequate equation 
to describe the response. 
Optimum formula was achieved from 
combination of contour plot for each 
parameter based on the goal (ln(Y1) : min, Y2 : 
min and Y3 : min) and importance (ln(Y1) : 4, 
Y2 : 2 and Y3 : 4). Based on superimposed 
contour plot optimum area was in range XG 
58-10mg, sodium bicarbonate 45-63mg, citric 
acid 7-25mg and tablet compressed in range 70-
98 N of hardness 
 
Drug release kinetics and mechanism 
Drug release kinetic was to describe the 
drug release from the dosage form. Controlled 
release formulation, swelling, diffusion and 
erosion are the most important rate-controlling 
mechanism and kinetics. Mechanism and 
kinetics  of   drug   releases   were   affected     by 
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characteristics of polymers, drug to polymer 
ratio and geometric of dosage form (Grassi and 
Grassi, 2005).  
The release exponent (n) indicates of the 
mechanism the drug release. An exponent value 
of cylindrical geometric n = 0.45 indicates 
Fickian diffusion, n within 0.45-0.89 indicates 
the anomalous transport, n = 0.89 indicates 
case II transport and n more than 0.89 indicates 
super case II transport. Based on the n value all 
formula within 0.45-0.89, thus indicates the 
drug release mechanism was controlled by 
diffusion and relaxation of the polymer chain 
and imbibition of water causing polymer 
change from glassy to rubbery state. Methocel® 
K15M CR was the polymer resistant with 
erosion and XG rapidly hydration thus 
combination of both polymer controlled drug 
release manner followed zero-order release. 
Drug kinetics release based on 
parameters on table II. Difference of 
formulation indicated different kinetics release. 
Selected kinetics model to describe the drug 
release based on goodness of fit (the highest of 
R2) and least fit square (the lowest of AIC and 
RMSE) thus similarity between observed and 
predicted model (Motoulsky and Christopoulus, 
2003). All formulas except Fabc were best 
fitted by Higuchi model and Fabc was best 
fitted by zero-order model. Shape curve 
parameter (β) of Weibull model indicates drug 
release with initial burst release (β<1) with the 
higher slope in initial time and followed by 
constant release. Hixson-Crowell model 
indicates the drug release occurs the surface of 
tablet diminish proportionally overtime 
(erosion). Highuci described drug release 
diffusion pass through the tortuosity of matrix 
followed fickian diffusion. Ideally, drug release 
from controlled release formulation with 
constant release rate (Costa and Lobo, 2001). 
 
CONCLUSIONS 
Floating lag time and drug release were 
affected by XG, effervescent components and 
hardness. Hardness was the most dominant 
Table II. Kinetics model of drug release from gastro-floating CAP tablet 
 
Model Statistics F1 Fa Fb Fab Fc Fac Fbc Fabc 
Zero-
order 
R2 0.939 0.947 0.954 0.959 0.946 0.969 0.976 0.978 
RMSE 6.37 4.88 5.93 4.69 5.06 3.22 3.10 2.55 
AIC 64.06 58.74 62.63 57.93 59.45 50.41 49.63 45.78 
First-
order 
R2 0.941 0.977 0.950 0.974 0.909 0.904 0.907 0.941 
RMSE 4.11 4.97 4.3 3.93 6.90 5.98 6.42 4.37 
AIC 52.25 56.04 53.30 51.33 62.61 59.73 61.15 53.48 
Higuchi 
R2 0.991 0.993 0.996 0.986 0.995 0.989 0.986 0.966 
RMSE 2.55 1.93 1.80 2.88 1.67 2.07 2.50 3.34 
AIC 42.68 37.07 35.69 45.15 38.29 42.06 44.38 54.94 
Hixson-
Crowell 
R2 0.947 0.914 0.957 0.948 0.861 0.873 0.876 0.925 
RMSE 6.29 6.52 6.07 5.58 8.51 6.89 7.41 4.94 
AIC 60.76 61.46 60.05 58.34 66.80 62.59 64.03 55.93 
Quadratic 
R2 0.968 0.967 0.957 0.971 0.908 0.912 0.902 0.943 
RMSE 5.17 4.31 6.43 4.39 7.36 6.07 6.99 4.57 
AIC 57.66 54.02 62.02 54.39 64.71 60.87 63.67 55.21 
Weibull 
R2 0.995 0.995 0.976 0.985 0.988 0.990 0.977 0.979 
β 0.811 0.732 0.745 0.716 0.674 0.613 0.602 0.637 
RMSE 1.72 1.11 3.91 2.42 2.43 2.80 3.80 3.25 
AIC 37.92 29.16 54.27 46.70 44.76 47.62 53.71 50.63 
Korsmeye
r-Peppas 
R2 0.990 0.987 0.998 0.993 0.981 0.996 0.990 0.990 
n 0.604 0.606 0.539 0.584 0.538 0.519 0.494 0.556 
RMSE 1.96 1.28 1.11 1.40 1.57 1.75 2.22 2.07 
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factor affected the floatation behavior. 
Increasing hardness and XG reduced the drug 
release at initial time and drug release. 
Increasing the sodium bicarbonate proportion 
increased the drug release and citric acid 
promoted initial burst release effect.  
Based on superimposed contour plot 
optimum area was found in range XG 58-
100mg, sodium bicarbonate 45-63mg, citric 
acid 7-25mg and hardness 70-98N. 
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